Document Detail


Utilization of positron emission tomography in the management of patients with sarcoma.
MedLine Citation:
PMID:  19412096     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) is being used with increased frequency in the care of patients with sarcoma. In this review, the recent literature covering all aspects of PET imaging in the management of patients with soft tissue and bone sarcomas will be discussed. RECENT FINDINGS: In a prospective multicenter study, PET imaging accurately detected primary tumors as well as lymph node and bone metastases in patients with sarcoma. Limitations in detecting lung metastasis can be overcome by using a hybrid PET/CT scanner. In patients with neurofibromatosis, 18F-FDG-PET demonstrated its application to detect and monitor for the malignant transformation of neurofibromas. Changes in tumor 18F-FDG uptake correlate significantly with histopathologic response and survival in patients with sarcoma. SUMMARY: PET imaging is emerging as an important imaging modality in the management of patients with sarcoma. Its applications include tumor grading, staging, therapeutic monitoring, and prognostication in adult and pediatric populations.
Authors:
Matthias R Benz; Nishan Tchekmedyian; Fritz C Eilber; Noah Federman; Johannes Czernin; William D Tap
Related Documents :
9867146 - Fluorine-18-fluorodeoxyglucose pet identification of cardiac metastasis arising from ut...
19474116 - High suv uptake on fdg-pet/ct predicts for an aggressive b-cell lymphoma in a prospecti...
19509556 - Influence of 2-(18f) fluoro-2-deoxy-d-glucose positron emission tomography/computed tom...
18094296 - Accuracy of preoperative t-staging of gallbladder carcinoma using mdct.
21094376 - Alignment of high resolution magic angle spinning magnetic resonance spectra using warp...
17928236 - Automatic curvilinear reformatting of three-dimensional mri data of the cerebral cortex.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in oncology     Volume:  21     ISSN:  1531-703X     ISO Abbreviation:  Curr Opin Oncol     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-10     Completed Date:  2009-07-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007265     Medline TA:  Curr Opin Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  345-51     Citation Subset:  IM    
Affiliation:
Departments of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California 90095, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Neoplasms / pathology,  radionuclide imaging*
Dideoxynucleosides / diagnostic use
Fluorodeoxyglucose F18 / diagnostic use
Humans
Neoplasm Staging
Osteosarcoma / pathology,  radionuclide imaging*
Positron-Emission Tomography / methods
Radiopharmaceuticals / diagnostic use
Sarcoma / pathology,  radionuclide imaging*
Chemical
Reg. No./Substance:
0/Dideoxynucleosides; 0/Radiopharmaceuticals; 25526-93-6/alovudine; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anesthesia for the morbidly obese parturient.
Next Document:  Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and an...